Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Hormone Treatment for Breast Cancer

Overview

Some breast cancers need the hormones estrogen or progesterone to grow. These cancer cells have "receptors" on their surface that let hormones in. One type is called estrogen-receptor-positive (ER+) breast cancer. Another type is called progesterone-receptor-positive (PR+) breast cancer.

Hormone treatment may be used to keep these cancers from getting the hormones they need. It's like starving the cancer cells so they don't grow.

Treatment works in one of two ways:

  • It lowers the amount of hormones your body makes.
  • It blocks or changes the cell receptors. This keeps the hormones from getting inside to feed the cancer cells.

Hormone treatment may be used:

  • After treatment for early-stage breast cancer. This reduces the chance that the breast cancer will come back.
  • To shrink the size of the cancer before surgery.
  • To treat advanced breast cancer or breast cancer that has spread beyond the breast.
  • To help prevent breast cancer in people who are at higher risk for breast cancer. It can help lower their risk.

Types of hormone treatment

Medicines used for hormone treatment include:

  • Selective estrogen receptor modulators (SERMs). They block the cell receptors from letting in hormones. They include:
    • Tamoxifen (Nolvadex).
    • Toremifene (Fareston).
  • Aromatase inhibitors. These block the enzyme aromatase, which converts other hormones in your body to estrogen. They are used mostly in people who are past menopause. They include:
    • Anastrozole (Arimidex).
    • Exemestane (Aromasin).
    • Letrozole (Femara).
  • GnRH or LH-RH agonists. They stop your ovaries from making estrogen. They include:
    • Goserelin (Zoladex).
    • Leuprolide (Lupron).
  • Selective estrogen receptor down-regulators (SERDs). These block and change the receptors so that they can't take in estrogen.
    • Fulvestrant (Faslodex).
    • Elacestrant (Orserdu).

Sometimes the ovaries are removed with surgery or treated with radiation. This is done to stop the ovaries from making estrogen.

Side effects of treatment

The side effects of hormone treatment depend on the drug that is used.

Selective estrogen receptor modulators (SERMS).

Common side effects include hot flashes, vaginal dryness, less interest in sex, mood swings, and feeling very tired. These drugs also raise your risk for blood clots and endometrial cancer. And they may increase your risk of stroke and fatty liver disease.

Aromatase inhibitors.

These can cause joint pain, hot flashes, vaginal dryness, and less interest in sex. Using these medicines for a long time may cause bone thinning.

GnRH and LH-RH agonists.

These drugs can cause hot flashes, mood swings, and vaginal dryness. They can cause less interest in sex, trouble sleeping, and headaches. Risks also include bone thinning.

Selective estrogen receptor down-regulators (SERDs).

Common side effects include joint and muscle pain, lack of energy, nausea, vomiting, hot flashes, and a cough. These drugs may also increase your cholesterol and triglycerides.

Side effects of surgery

Removing your ovaries makes you start menopause, if you haven't started it yet. Menopause often has symptoms like hot flashes, vaginal dryness, urinating often, and having less interest in sex. And it raises your risk for other diseases, like heart disease and osteoporosis.

When your ovaries are removed, you can no longer get pregnant through sex.

Managing side effects

If symptoms—like joint pain, mood swings, and hot flashes—are mild, you may get some relief if you do physical activity, lower your stress, and dress in layers. Your doctor may recommend medicine for severe symptoms. Ask your doctor about ways to protect your bones if they're thinning because of treatment.

Related Information

Credits

Current as of: October 25, 2024

Author: Ignite Healthwise, LLC Staff
Clinical Review Board
All Ignite Healthwise, LLC education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Current as of: October 25, 2024

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Ignite Healthwise, LLC education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

5115 Fannin, Suite 801
Houston, TX 77004

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary